|
Pharma bridge for 2 continents - Europe, Asia
|
|
Our Bureau, Mumbai
April 01 , 2015
|
|
|
CPhI Istanbul, the gateway to pharma markets of Middle-East and North Africa, Eurasia, Central Asia and the Caucasus will be held from June 3-5, 2015, at ICC Istanbul Congress Center, Turkey.
The Turkish pharmaceutical market is expected to reach US$23.3 billion by 2023 and the Middle East and North Africa (MENA) region constitute 2% of global pharmaceutical sales. Istanbul is the only city in the world that bridges two continents, Europe and Asia, and its strategic stand geographical positioning makes this event a unique platform for global buyers and suppliers to meet with decision makers from the region.
CPhI Istanbul and co-located events ICSE, P-MEC and InnoPack will bring together regional drug manufacturers with global suppliers of raw materials, machinery, packaging solutions and contract services. While CphI Brings together buyers and suppliers of pharmaceutical ingredients, ICSE connects the pharma community with outsourcing solution providers, P-MEC showcases the newest Pharma machinery, equipment and technology and InnoPack hosts the latest innovations in packaging and drug delivery systems.
High profile people from range of business sectors including APIs, Fine chemicals and Intermediates, Finished formulations, Bio-pharmaceuticals, excipients are exhibiting in the event, while the co-located events brings business people from contract services, technology and machinery, custom manufacturing, packaging and drug delivery.
CPhI Istanbul is the pharma event to access new business opportunities in the MENA and Central Asia & Caucasus regions. By exhibiting and visiting at CPhI Istanbul, professionals will get a chance to meet new faces and top level executives, establish relationships with leading Eurasia pharma companies and government institutions, identify business opportunities - Meet face to face with, meet 4,000+ attendees with senior level pharma titles advantages of CPhI global marketing program and successful track record of many geo-adaptations.
The region’s pharma market is poised for growth
According to the OECD, Turkey is expected to be the fastest growing economy of its members, with expected annual average growth rate of 6.7%between 2011-2017. Total end-user spending is projected at USD $9.1 billion, which makes Turkish pharmaceutical sector rank 7th in Europe and 16th in the world according to the AiFD (Association of Research-Based Pharmaceutical Companies in Turkey). A rapid increase in the population in the Middle East and the North Africa (MENA) regions. Of the 22 countries in the region, Turkey, Israel, Saudi Arabia and Egypt stand out as the largest markets in terms of projected growth potential and value representing a host of opportunities. Huge demand for not only medicines but also medical equipments is foreseen as governments expand healthcare delivery systems to match the growing population and encourage the private sector to participate. From 2011 to 2015, 33 investment projects with a value of nearly 400mln USD are planned for establishing new and modernising existing pharmaceutical industries in the MENA and Central Asian region.
CPhI Conference
Stepping into a new market requires knowledge about the regulatory environment, business culture and market opportunities. The CphI Istanbul conference is specifically designed to provide invaluable insights into the fast-growing Turkish and regional pharmaceutical markets. With sessions from government institutions, key pharma companies and thought-leaders, the conference gives you all the information you need to successfully establish your business in this region.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|